Loading…
Loading grant details…
| Funder | Wellcome Trust |
|---|---|
| Recipient Organization | Massachusetts Institute of Technology |
| Country | United Kingdom |
| Start Date | Oct 01, 2024 |
| End Date | Mar 31, 2026 |
| Duration | 546 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | 313367 |
We propose to sensitise brain MRI to cell type numbers, shapes, and connectivity. The goal in each case is to achieve cell specificity.
We will do so by (1) developing novel molecular MRI contrasts that provide cell or molecule specific signatures read out through the widely used BOLD signal, by (2) enhancing diffusion MRS to provide tissue microstructure intracellularly to distinguish between neuronal, astrocyte, and microglia morphology, and by (3) combining high resolution diffusion and quantitative MRI with 2D and 3D histology and transcriptomics to generate models that can predict cell distribution and optimise mesoscopic brain connectivity.
At the end of the eight year project we will have significantly advanced our ability to use MRI as a cell-specific readout of brain architecture and provided key insights into how variation in the cellular architecture of the brain leads to variation in risk and resilience in mental health.
Massachusetts Institute of Technology
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant